Northwest Neurospecialists, PLLC

Tucson, Arizona 85741-3537

0 studies enrolling now · 20 studies all time

What they study most

Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Orthostatic Hypotension, Parkinson's Disease, Psychotic Disorders, Relapsing Remitting Multiple Sclerosis, Spasticity

Studies at this site

• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis — Withdrawn before enrolling
• A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis — Completed
• A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease — Completed
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx — Completed
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease — Completed
• SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease — Stopped early
• A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil — Stopped early
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed